You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Colorcon
Express Scripts
AstraZeneca
Boehringer Ingelheim
Dow
Baxter

Last Updated: February 23, 2020

DrugPatentWatch Database Preview

Litigation Details for Smith Kline & French Laboratories Limited v. Teva Pharmaceuticals USA Inc. (D. Del. 2005)


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

Smith Kline & French Laboratories Limited v. Teva Pharmaceuticals USA Inc. (D. Del. 2005)

Docket   Start Trial Date Filed 2005-04-06
Court District Court, D. Delaware Date Terminated 2007-03-15
Cause 35:271 Patent Infringement Assigned To Gregory Moneta Sleet
Jury Demand None Referred To
Parties SMITH KLINE & FRENCH LABORATORIES LIMITED; SMITHKLINE BEECHAM CORPORATION; TEVA PHARMACEUTICALS USA INC.
Patents 4,452,808; 4,824,860; 5,641,803; 9,127,013
Attorneys John W. Shaw; Josy W. Ingersoll; Karen Elizabeth Keller; Monte Terrell Squire; Patricia Smink Rogowski
Firms Shaw Keller LLP; Young, Conaway, Stargatt & Taylor LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Smith Kline & French Laboratories Limited v. Teva Pharmaceuticals USA Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial , and   Start Trial .

Details for Smith Kline & French Laboratories Limited v. Teva Pharmaceuticals USA Inc. (D. Del. 2005)

Date Filed Document No. Description Snippet Link To Document
2005-07-21 13 Status Report United States Patent Nos. 4,452,808 {“the ‘808 patent”`) and 4,824,860 (“the ‘860 patent”) by submitting…) tire vaiidity of the ‘808 patent; (b) the vahdity of the ‘86{) patent; (c) Whether the filing of the…claim of the ‘860 patent; and (e) vvhether infringement of the ‘SOS and/or ‘860 patent (if found) Was otis…earlier than the expiration ofboth the ‘808 patent and the ‘860 patent; {d) an Order permanently enjoining Teva…until after expiration of both the ‘808 patent and the ‘860 patent; (e) reasonable attorneys fees, filing External link to document
2006-10-30 132 Exhibit A, Part 1 ultimately allowed by the patent examiner in U.S. Patent Nos. 4,452,808 (the “’808 patent”) and 4,824,860 (the…litigation The first, United States Patent No. 4,452,808 (the “’808 patent”), covers the compound itself`.…compound It is a function of a patent attorney or patent agent to seek patent claims as broad as possible… for patentability defined in the patent statute, 35 U.S.C § 101, et. seq. lt is up to the patent examiner…of the ‘808 patent and the ‘860 patent set forth in the specifications of these two patents. In the absence External link to document
2006-11-06 140 Answering Brief in Opposition case, one of the asserted patents, U.S. Patent No. 4,452,808 (“the ‘808 patent”), is directed to chemical…received U.S. Patent No. 4,824,860 (“the ‘860 patent”) based on his invention Both patents include genus…normal patent prosecution practice at the time the patents were being considered by the Patent Ofiice.…disclosed in both the asserted patents and a prior art GSK patent As a patent lawyer with a technical background…and did not do. 'i`he Patent Ofiice allowed genus claims in both patents because the discovery of External link to document
2006-11-06 141 Exhibit A ultimateiy ailowed by the patent examiner in U.S. Patent Nos. 4,452,808 (the “’808 patent") and 4,824,860…litigation The tirst, United States Patent No. 4,452,808 (the “‘808 patent” , covers the compound itself Ttie…compound lt is a function of a patent attorney or patent agent to seek patent ciairns as broad as possible… for patentability defined in the patent statute, 35 U.S.C § lOl, et. seq. lt is up to the patent examiner…of the ‘808 patent and the ‘860 patent set forth in the speciiications of these two patents ln the absence External link to document
2006-11-06 143 Answering Brief in Opposition subject matter claimed in U.S. Patent No. 4,452,808 (“the ‘808 patent”) and U.S. estes Ne. 4,324,360 …GSK~ owned patents reiating to ropiniroie hydrochloride: United States Patent No. 4,452,808 (“the °808…supported by the patent specification Tbe basis ot` patentability of the ‘860 patent was that the indoione…drafting the patent application for the ‘808 patent (Williarn Edgerton) and the ‘860 patent CVincent Fabiano…Invention of the Patents-in-Suit and No. 4 to Exclude Evidence and Testimony on Patent Prosecution [PUBLIC External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Baxter
Merck
Moodys
Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.